Perfusion system and a method for the large scale production of virus or virus antigen

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5719051
SERIAL NO

08357292

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention resides in a matrix, i.e. in a carrier material, with human or animal cells adherently bound thereto, the cells being infected with virus. It has shown that surface-dependent cells suitable for virus propagation remain adherently bound to a matrix even in the virus-infected state, continuously produce virus antigen over relatively long periods of time and deliver them into the culture medium. For producing TBE virus antigen by growing tick-borne encephalitis (TBE) virus in cell cultures, a surface-dependent permanent cell line, preferably the Vero cell line ATCC CCL 81, is inoculated with TBE virus, and the cells are kept bound to carriers in a non-lyric serum-free system while maintaining the cell growth, so as to maintain antigen formation, whereupon the antigen-containing medium is separated form the carrier-bound cells and, in a known manner, is processed to a galencially acceptable preparation by concentration, inactivation and purification.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAXALTA INCORPORATED1200 LAKESIDE DRIVE BANNOCKBURN IL 60015
BAXALTA GMBH8152 GLATTPARK OPFIKON

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barrett, Noel Klosterneuburg/Weidling, AT 23 407
Dorner, Friedrich Vienna, AT 106 1742
Eibl, Johann Vienna, AT 116 1743
Mundt, Wolfgang Vienna, AT 87 1106

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation